NCT02525133View on ClinicalTrials.gov

Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty

PHASE3CompletedINTERVENTIONAL

Enrollment

319

Participants

Timeline

Start Date

September 5, 2015

Primary Completion Date

April 22, 2016

Study Completion Date

April 22, 2016

Conditions

Pain, Postoperative

Interventions

DRUG

XaraColl

Surgical implantation of 3 bupivacaine collagen implants

OTHER

Placebo

Plain collagen implant (vehicle)

Trial Locations (24)

19104

Philadelphia

23606

Newport News

27710

Durham

31904

Columbus

32503

Pensacola

33028

Pembroke Pines

33134

Miami

33155

Miami

35216

Birmingham

36207

Anniston

43210

Columbus

44106

Cleveland

53792

Madison

60645

Chicago

73104

Oklahoma City

77004

Houston

77024

Houston

80045

Aurora

84124

Salt Lake City

89104

Las Vegas

91105

Pasadena

92653

Laguna Hills

92801

Anaheim

92870

Placentia

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Innocoll

INDUSTRY